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INTRODUCTION
It had been thought that patients with homocystinuria,
due to cystathionine β-synthase (CBS) deficiency, showed
elevated concentrations of both homocyst(e)ine and
methionine in the blood and urine even in the neonatal
period. For this reason, the blood level of methionine is
routinely measured in neonates in Japan in the mass
screening for CBS deficiency. We report two siblings with
vitamin B6-nonresponsive CBS deficiency with differing
blood methionine levels, one of which was missed in the
screening of newborns for homocystinuria.
PATIENTS
Case 1 : A 9-year-old boy had CBS deficiency, as pre-
viously reported(1). His parents were not consanguineous.
He was fed with normal milk formula and his protein
intake was about 2.5 g/kg body weight/day at 5 days old.
Although hypermethioninemia was detected on routine
screening at 5 days old, diagnosis of homocystinuria was
not made until he was 3 months old because of undetect-
able urinary levels of homocystine, and of undetectable
plasma levels of non-protein-bound homocyst(e)ine.
Homocystine was detected in urine at 3 months old and a
marked reduction in CBS activity was observed in
cultured skin fibroblasts (Table 1 and 2). A marked
elevation of total plasma homocyst(e)ine was present at
the age of 19 and 59 days, as determined in specimens
that had been frozen at -20℃ for 3 years (71.7 and 66.9
μmol/l, respectively ; normal 6.4-10.2 μmol/l) (Table 1).
Since this patient did not respond to high dosages of
vitamin B6 (500 mg daily for 10 days), a low methionine
diet and betaine were initiated. His subsequent physical
and psychomotor development was normal.
Case 2 : A 7-year-old girl, the younger sister of case 1.
She had been delivered after 41 weeks of gestation with
no complication. She weighted 3,352 g at birth. She was
fed with normal milk formula and her protein intake was
about 2.5 g/kg body weight/day at 5 days old. However,
her blood concentration of methionine was below the
normal cut-off value in mass screening at 5 days old ;
i.e., less than 67 μmol/l (Table 1). While her physical
development was normal, she exhibited retardation,
especially of speech development. At the age of 2.5 years
she visited Tokushima University Hospital. At that time
her development quotient was 57. A test for cyanide-
nitroprusside in urine was positive. Analysis of amino
acids in plasma and urine gave the following values :
plasma methionine and plasma total homocyst(e)ine, 556
μmol/l (normal ; 20-50 μmol/l) and 95.7 μmol/l (normal ;
6.4-10.2 μmol/l) ; urinary levels of methionine and homo-
cystine, 0.59 μmol/mg creatinine (normal ; trace-0.10
μmol/mg creatinine) and 1.03 mmol/mg creatinine (nor-
mally undetectable). No activity of CBS was detected in
cultured skin fibroblasts (Table 2). Since the patient failed
to respond to high doses of vitamin B6 (500 mg daily for 8
days), she was administered a low methionine diet and
betaine. Her IQ rose from 57 at age of 2.5 years to 99 at
age of 6.5 years.
DISCUSSION
Newborn infants with homocystinuria are classified into
three groups according to the blood level of methionine
and the urinary level of homocystine : Group 1 - patients
with hypermethioninemia and homocystinuria in the
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neonatal period (2) ; Group 2 - patients with hyper-
methioninemia but no homocystinuria in the neonatal
period, but who clearly excrete homocystine in urine later
(1, 3), and Group 3 - patients with a normal serum
concentration of methionine in the neonatal period, but
who subsequently exhibit hypermethioninemia and
homocystinuria (3). The metabolism of methionine and
homocyst(e)ine is catalyzed in the fetus and adults by
several enzymes with quantitatively differing activities.
The specific activities of methionine adenosyltransferase
and betaine-homocysteine methyltransferase are lower in
the fetal liver than the adult liver, whereas the activity of 5-
methyltetrahydrofolate-homocysteine methyltransferase
is higher in fetal tissue than adult tissue (4, 5). This fetal
enzyme pattern should direct a large portion of the
available homocysteine to the 5-methyltetrahydrofolate-
dependent methylation cycle rather than toward the
synthesis of cystathionine, then change to an adult pattern
during development. The failure to detect homocystinuria
or hypermethioninemia in some newborn infants with a
deficiency of CBS may therefore be explained by a
quantitative difference in the activities of enzymes
involved in the metabolism of methionine and homocyste-
ine for first few weeks or months after birth (6).
Case 1 belonged to Group 2, while case 2 belonged to
Group 3. Hypermethioninemia was found during the
neonatal period in case 1, whereas the urinary excretion of
homocystine was so slight that it was undetected until the
age of 3 months. It is known that homocystine is easily
bound to plasma protein (7, 8). No plasma non-protein-
bound homocystine was detected
in case 1, even though the plasma
level of total homocyst(e)ine had
increased markedly (close to a 10
fold increase over the normal level)
at 19 and at 59 days old. Several
patients with a deficiency in CBS
had no detectable or only mild
increases in plasma non-protein-
bound homocyst(e)ine when the
plasma level of protein-bound
homocyst(e)ine was 10-fold higher
than the normal level (7, 9).
No examination of homocyst(e)ine
was performed in case 2 during
the neonatal period, because her
methionine level was not elevated.
The assay of enzyme activity in the
cultured skin fibroblasts confirmed a
deficiency in CBS. Most vitamin B6-
responsive patients with CBS
deficiency are missed on newborn
screening, because the blood level of
methionine is not sufficiently
elevated in the plasma during the
first few days of life(6). However, our
patients did not have a vitamin B6-
responsive form of CBS deficiency.
As shown by our patients, their
blood methionine levels in the neonatal period seemed to
fluctuate, even though they were siblings with the same
genetic defect. These findings indicated that in
homocystinuric neonates the blood levels of methionine
were determined not only by the genetic defect in CBS,
but also by the activity of other enzymes involved in
methionine metabolism and dietary intake of methionine.
Poor protein intake can be excluded as a cause in our
patient. Therefore, we suggest that the activities of
enzymes other than CBS in methionine metabolism
probably differed in the neonatal period in these patients.
Thus, genotype may not always be consistent with
phenotype in patients with inherited diseases (10).
Considering its position in the metabolic pathway,
homocyst(e)ine is nearest to CBS, whereas methionine is
distal to it. Accordingly, we suggest that a defect in CBS
leads to a more obvious rise in homocyst(e)ine vs. that of
methionine. It is probable that blood homocyst(e)ine
closest to the block at this enzyme had increased in the
neonatal period in case 2, despite a normal blood level of
methionine. Therefore, in the newborn screening of CBS
deficiency, a new method for determining the blood level
of homocyst(e)ine should be developed and evaluated
properly to avoid missing patients with CBS deficiency.
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